Description: Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.
Home Page: www.biosynex.com
22 Boulevard SEbastien Brant
Illkirch-Graffenstaden,
67400
France
Phone:
33 3 88 78 78 87
Officers
| Name | Title |
|---|---|
| Mr. Larry Abensur | Chairman & CEO |
| Dr. Thierry Paper | Deputy CEO & Director |
| Mr. Thomas Lamy | Deputy CEO & Director |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.172 |
| Price-to-Sales TTM: | 0.1717 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 515 |